Literature DB >> 11709064

Structure, function and regulation of the 5-hydroxytryptamine (serotonin) transporter.

S Horschitz1, R Hummerich, P Schloss.   

Abstract

The serotonin transporter (SERT), which terminates serotonergic neurotransmission by rapid re-uptake of 5-hydroxytryptamine (5-HT) back into the nerve terminal was the subject of two studies. First, the regulatory effects of antidepressants on the expression of SERT was investigated. After chronic exposure of SERT to antidepressants, substrate transport and antidepressant binding parameters were determined. Long-term exposure of SERT to a selective 5-HT-re-uptake inhibitor, citalopram, resulted in the down-regulation of the expression level. The observed effects depend on drug concentration and exposure time and are reversible. Basal uptake levels could be regained 48 h after cessation of the treatment. Secondly, in order to gain insight into the molecular mechanism of substrate transport, potential interactions of SERT with the noradrenaline transporter (NET) have been investigated. A chimeric concatameric transporter construct consisting of rat SERT and rat NET has been cloned and characterized pharmacologically in a heterologous expression system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709064     DOI: 10.1042/0300-5127:0290728

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  13 in total

1.  Regulation of the Serotonergic System by Kainate in the Avian Retina.

Authors:  Adelaide da Conceição Fonseca Passos; Anderson Manoel Herculano; Karen R H M Oliveira; Silene Maria A de Lima; Fernando A F Rocha; Hércules Rezende Freitas; Luzia da Silva Sampaio; Danniel Pereira Figueiredo; Karin da Costa Calaza; Ricardo Augusto de Melo Reis; José Luiz Martins do Nascimento
Journal:  Cell Mol Neurobiol       Date:  2019-06-13       Impact factor: 5.046

2.  Functional constituents of a local serotonergic system, intrinsic to the human coronary artery smooth muscle cells.

Authors:  Kannan Baskar; Swastika Sur; Vithyalakshmi Selvaraj; Devendra K Agrawal
Journal:  Mol Biol Rep       Date:  2015-04-11       Impact factor: 2.316

3.  Reduced signal transduction by 5-HT4 receptors after long-term venlafaxine treatment in rats.

Authors:  R Vidal; E M Valdizan; M T Vilaró; A Pazos; E Castro
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

4.  Maternal depression and anxiety are associated with altered gene expression in the human placenta without modification by antidepressant use: implications for fetal programming.

Authors:  Kathryn L Ponder; Amy Salisbury; Bethany McGonnigal; Alyse Laliberte; Barry Lester; James F Padbury
Journal:  Dev Psychobiol       Date:  2011-05-05       Impact factor: 3.038

5.  Serotonin transporter clustering in blood lymphocytes of reeler mice.

Authors:  Tania Rivera-Baltanas; Raquel Romay-Tallon; Iria G Dopeso-Reyes; Héctor J Caruncho
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-04-21

6.  Pharmacokinetic-pharmacodynamic modelling of fluvoxamine 5-HT transporter occupancy in rat frontal cortex.

Authors:  M Geldof; J I Freijer; L van Beijsterveldt; X Langlois; M Danhof
Journal:  Br J Pharmacol       Date:  2008-05-19       Impact factor: 8.739

7.  Imaging of serotonin transporters and its blockade by citalopram in patients with major depression using a novel SPECT ligand [123I]-ADAM.

Authors:  N Herold; K Uebelhack; L Franke; H Amthauer; L Luedemann; H Bruhn; R Felix; R Uebelhack; M Plotkin
Journal:  J Neural Transm (Vienna)       Date:  2006-02-09       Impact factor: 3.850

8.  Postnatal changes in tryptophan hydroxylase and serotonin transporter immunoreactivity in multiple brainstem nuclei of the rat: implications for a sensitive period.

Authors:  Qiuli Liu; Margaret T T Wong-Riley
Journal:  J Comp Neurol       Date:  2010-04-01       Impact factor: 3.028

9.  Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved.

Authors:  Thibault Renoir
Journal:  Front Pharmacol       Date:  2013-04-16       Impact factor: 5.810

10.  In vivo quantification of the [(11)C]DASB binding in the normal canine brain using positron emission tomography.

Authors:  Olivia Taylor; Nick Van Laeken; Filip De Vos; Ingeborgh Polis; Tim Bosmans; Ingeborg Goethals; Rik Achten; Andre Dobbeleir; Eva Vandermeulen; Chris Baeken; Jimmy Saunders; Kathelijne Peremans
Journal:  BMC Vet Res       Date:  2015-12-24       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.